Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21360625

Download in:

View as

General Info

PMID
21360625